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ABSTRACT 
The simulated patient methodology (SPM) is a form of participatory observation and can be used to assess the quality of counselling. The aim is to 
review those papers reporting the use of the SPM in German community pharmacies (CPs) from the beginning of 2005 to the end of 2018. The 
reporting items in the study were derived from the PRISMA Statement. We conducted a systematic search in the GVK-Plus, Embase, Web of Science, 
PubMed and Google Scholar databases. Additional sources included the personal literature collection of 1 of the reviewers and the reference lists 
from international systematic reviews and potentially relevant papers. The quality of the papers included was evaluated using the AXIS tool. A total 
of 5 papers were included. The SPM that was used varied greatly in the papers. The quality of counselling was assessed in the papers as being rather 
poor. The quality of the papers differed for specific assessment criteria. Only an extremely small number of papers could be included, in contrast to 
other countries. The papers for Germany demonstrate that there is a considerable need for improvement in the quality of counselling in CPs. Also, 
the deficits identified here for the application of the SPM should be avoided in future papers. It must also be recommended that the SPM be reported 
in future papers using uniform reporting standards, which are yet to be developed, to ensure better comparability. 
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INTRODUCTION 
Depending on the laws in a country, defined establishments are 
authorised to dispense 2 fundamentally different groups of 
medications, prescription-only medicines (POM) and over-the-
counter medicines (OTC) for which no prescription is required. 
Compared to countries in which OTC medicines and even POMs can 
be dispensed outside community pharmacies (CPs), such as by 
doctors or in supermarkets or petrol stations [1], in Germany, it is 
almost exclusively CPs and the mail-order pharmacies operated by 
them that are authorised to dispense such medicines [2]. Only 
specific OTC medicines (e. g., curative waters, medicinal clays) are 
not pharmacy-only medicines and can, for example, be sold in 
drugstores as well [2, 3]. Because this market segment plays a minor 
role, CPs are the most significant location for the dispensing of POMs 
and OTC medicines in the German medicinal product market [4]. 
The importance of CPs in Germany (31.12.2018: approx. 83 million 
residents; 19,423 CPs; a density of approx. 23 CP per 100,000 
residents, making it below-average in the EU comparison [5, 6]) is 
also derived from the fact that they must satisfy certain 
requirements. These requirements include providing counselling for 
medicines that must be conducted by pharmacists but can also be 
carried out by pharmacy technicians and pharmaceutical technical 
assistants if this has been previously specified by the pharmacy 
manager [7]. The legally envisaged objective is that the CPs provide 
an ‘adequate’ quality of counselling [7]. This objective is intended to 
be achieved using the internal quality management system operated 
by the CPs, whereas external quality assessments remain only a 
recommendation at this stage [7]. In this context, the Federal 
Chamber of Pharmacies provides guidelines and, for several 
indications, corresponding tools [8]. For external quality assurance, 
each regional chamber of pharmacists carries out regular 
inspections of the quality of counselling provided by CPs [9]. As a 
matter of principle, first and foremost, independent scientific 
studies–also to achieve the least distorted results possible–are of 
great importance for clarifying the extent to which CPs provide an 
‘adequate’ quality of counselling.  
Regarding the methodology to be used, there are several options 
available for investigating the quality of counselling in CPs. These 
include surveys, interviews of the persons involved (customers, 
pharmacy staff), clinical vignettes and non-participatory 
observations [10, 11]. The validity of surveys, interviews and clinical 
vignettes as a means of assessing quality is limited due to social 
desirability bias because in particular, pharmacy staff who are 
surveyed or interviewed tend to describe their counselling 
performance as better than what was provided [12]. For non-
participatory observations, there is the drawback that the pharmacy 
staff generally modify their behaviour when they become aware that 
they are being observed. This behavioural adaptation is known as 
the Hawthorne effect [13] and can lead to an overly good quality of 
counselling compared to the everyday situation. Therefore, to avoid 
the problems described above, the simulated patient methodology 
(SPM) [14-16], which has often been used in the past in the CP 
setting to assess the quality of counselling, is recommended [17, 18]. 
The SPM is, as defined in the international literature [14-16], a 
covert participatory observation by a person, who in an ideal case, 
cannot be differentiated from a real customer (simulated patient, 
SP), who visits a CP to simulate a real-life counselling situation based 
on a previously defined scenario. The data are then collected 
according to previously defined criteria using an assessment form 
and the CP is provided with performance feedback, if applicable. The 
SPM is considered the gold standard in the international literature 
[11], even if its relatively high administrative and financial costs and 
the comparatively smaller sample sizes [11], as well as any intra-and 
inter-observer variabilities, are taken into account [19]. 
This study aims to review papers reporting on the use of the SPM for 
assessing the quality of counselling in German CPs. To ensure that 
the object of the current investigation is as current as possible, only 
papers from the beginning of 2005 onwards will be reviewed. Due to 
the country-specific differences present, for example, regarding the 
subject contents of the pharmacy degree [20], the pharmacy density 
[21] or the guidelines used as a benchmark for a quality assessment 
[18], an international systematic review could lead to distortions in 
the results. For this reason, this study was limited to Germany. 
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MATERIALS AND METHODS 
The current study was reported using the reporting items defined in 
the ‘Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) Statement’ [22]. 
Literature search 
The search is derived from the recommendations of an umbrella 
review for implementing a regional limitation when searching for 
papers from Germany [23]. In July 2019 a search was conducted 
for papers that had been published between the beginning of 2005 
and the end of 2018. The systematic search (table 1) was 
conducted in the following online databases by 1 of the reviewers: 
GVK-Plus, Embase, Web of Science, PubMed and Google Scholar. 
The choice of search terms regarding the term ‘simulated patient’ 
was based on the synonyms used in international systematic 
reviews [14-16]. The synonyms were combined with other search 
terms. If the preferred search option ‘Title/Abstract’ was not 
available in the online databases, ‘Abstract’ or ‘Title’ was selected. 
Additionally, the other reviewer searched manually in his 
literature collection and the reference lists of international 
systematic reviews [14-16]. 
 
Table 1: Search strategy for the systematic search in online databases 
Search terms algorithm with German search terms 
(21 different search combinations per database) 
‘simulierter Patient’ or ‘simulierter Besucher’ or ‘simulierter Käufer’ or 
‘simulierter Verbraucher’ or ‘simulierter Klient’ or ‘simulierter Kunde’ or ‘Testkäufer’ 
AND 
‘öffentliche Apotheken’ or ‘Vor-Ort-Apotheken’ or ‘Präsenzapotheken’ 
Search terms algorithm with English search terms 
(264 different search combinations per database) 
‘simulated patient’ or ‘simulated customer’ or ‘simulated client’ or 
‘simulated shopper’ or ‘simulated patron’ or ‘simulated participant’ or 
‘standardised patient’ or ‘standardised customer’ or ‘standardised client’ or 
‘standardised shopper’ or ‘standardised patron’ or ‘standardised participant’ or 
‘standardized patient’ or ‘standardized customer’ or ‘standardized client’ or 
‘standardized shopper’ or ‘standardized patron’ or ‘standardized participant’ or 
‘undercover patient’ or ‘undercover customer’ or ‘undercover client’ or 
‘undercover shopper’ or ‘undercover patron’ or ‘undercover participant’ or 
‘mystery patient’ or ‘mystery customer’ or ‘mystery client’ or 
‘mystery shopper’ or ‘mystery patron’ or ‘mystery participant’ or 
‘secret patient’ or ‘secret customer’ or ‘secret client’ or 
‘secret shopper’ or ‘secret patron’ or ‘secret participant’ or 
‘pseudo patient’ or ‘pseudo customer’ or ‘pseudo client’ or 
‘pseudo shopper’ or ‘pseudo patron’ or ‘pseudo participant’ or 
‘covert patient’ or ‘covert customer’ or ‘covert client’ or 
‘covert shopper’ or ‘covert patron’ or ‘covert participant’ or 
‘surrogate patient’ or ‘surrogate customer’ or ‘surrogate client’ or 
‘surrogate shopper’ or ‘surrogate patron’ or ‘surrogate participant’ or 
‘disguised patient’ or ‘disguised customer’ or ‘disguised client’ or 
‘disguised shopper’ or ‘disguised patron’ or ‘disguised participant’ or 
‘fictitious patient’ or ‘fictitious customer’ or ‘fictitious client’ or 
‘fictitious shopper’ or ‘fictitious patron’ or ‘fictitious participant’ 
AND 
‘community pharmacies’ or ‘community pharmacists’ 
AND 
‘German’ or ‘Germany’ 
Online database Provider Date of searching Search option Records 
With German search terms 
GVK-Plus VZG 26.07.2019 ‘Title’ 0 
With English search terms 
Embase Ovid 31.07.2019 ‘Abstract’ 6 
Web of Science Clarivate Analytics 30.07.2019 ‘Title’ 1 
PubMed NCBI 28.07.2019 ‘Title/Abstract’ 6 




Inclusion and exclusion criteria 
A selection process was then carried out by the 2 reviewers 
independently of each other (fig. 1). According to the current object 
of investigation, it was aimed to include papers that assessed the 
quality of counselling in German CPs using the SPM. The CPs must 
have been physically visited in the papers. Papers were also included 
regardless of the mode of publication, the type of medicines 
investigated and the study design. The papers also had to be publicly 
accessible original research with transparent details about the 
methodology used and had to be written in German or English. 
Papers were excluded that did not describe original research (e. g. all 
types of reviews), that were carried out in pharmacies outside 
Germany or published in a language other than German or English, 
that were conducted in a non-community pharmacy setting (e. g. 
hospital pharmacies) or using soft quality factors for the counselling 
(e. g. non-verbal skills) and other SPMs that did not require a 
physical visit to the CPs (e. g. mystery calls). 
Eligibility 
After excluding duplicates, the titles and, if available, the abstracts of 
the records were screened. The full text of the remaining potentially 
relevant papers was then screened. This was then followed by a 
manual review of the reference lists (backward snowballing) of the 
remaining potentially relevant papers for possible inclusion in the 
list of potentially relevant papers found up to that point [24]. 
Because the aim of this systematic review was to investigate papers 
and not studies, in the end, all papers were included regardless of 
whether they reported about the same study. 
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Fig. 1: Flow diagram; derived from the PRISMA statement [22] 
 
Data extraction 
The data extraction subsequently carried out by both reviewers 
independently of each other was performed using the 2 major 
criteria ‘use of the simulated patient methodology’ (5 minor criteria: 
scenarios, community pharmacies, simulated patients, visits, data 
collection and performance feedback) and ‘assessment of the quality 
of counselling’. The minor criteria were derived primarily from the 
criteria in PICOS [25] and from those criteria that were used in 
international systematic reviews [14-16]. The criteria prepared in 
this way were then summarised in a corresponding form that was 
used as the basis of the qualitative synthesis of the data extracted 
from the papers. Due to the heterogeneity of the papers included, we 
refrained from generating a meta-analytical summary. 
Quality assessment 
The quality of the papers included was also assessed using the AXIS 
tool. This tool addresses the quality of reporting and the quality of 
design as well as the risk of bias [26]. The assessment was carried 
out by both reviewers independently of each other with neither 
reviewer having previously used the tool. The inter-rater reliability 
was measured using Cohen’s kappa (κ) [27]. 
Ethical approval 
Not applicable as no human subjects were involved. 
RESULTS 
Included papers 
Initially, 23 records were identified. After duplicates were removed 
and the titles and, if applicable, the abstracts were screened, 13 
papers remained; after excluding 1 [28] there were then 12 
potentially relevant papers available. Of these, 7 potentially relevant 
papers [29-35] were excluded after screening the full text. Using a 
manual review of the reference lists of the now 5 potentially 
relevant papers, no further papers were identified. In the end, 5 
papers [36-40] were included. Of these 5, 2 papers [38, 39] reported 
about the same study. In addition, 1 paper [40] was a follow-up to a 
previously conducted baseline study [38, 39]. Further general 
information about the included papers is shown in table 2. 
Use of the simulated patient methodology 
All information about the SPM used in the included papers can be 
seen in table 3 and table 4. 
Scenarios 
The 5 included papers applied relevant scenarios to simulate a real-
life counselling situation: 2 papers used 2 scenarios [36, 37] and the 
other 3 papers used 4 scenarios [38-40]. In 1 scenario [36, 37] and 2 
scenarios [38-40] respectively, the SPs started the consultation 
either by providing symptom-based information or making a 
medication-based request. The person for whom the medication was 
requested or whose symptoms were described was the SP 
themselves in 2 papers [36, 37] and in the other 3 papers [38-40] it 
was a third person. The particular person concerned was revealed in 
11 of 12 scenarios upon enquiry by the pharmacy staff. In 1 scenario 
in 1 paper [37], the information about the person concerned was 
provided at the start of the consultation. In 3 papers [38-40], the 
practical functionality of the scenarios was tested. These pre-tests 
were carried out in CPs outside the planned study region. The other 
2 papers [36, 37] did not provide any information about possible 
pre-tests.
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Table 2: General information 
 Berger et  al. 2005 [36] Alte et  al. 2007 [37] Langer et al. 2016 et al. 
2018 [38, 39] 
Langer et  al. 2018 [40] 
Year of execution n/s 2005 2014 2017 
Design CS CS CS CS 
Aim To evaluate counselling 
performance of staff in CPs 
and to assess the quality of 
patient counselling 
To estimate aspects of 
consultation quality in 
CPs, study factors 
related to consultation 
quality 
To assess the quality of 
counselling in CPs and to 
evaluate the role of the 
patient’s approach and 
different user groups in 
determining the outcome of 
counselling 
To analyse whether the quality 
of advice provided by CPs in the 
period between 2014 [38, 39] 
and 2017 [40] could be 
increased and to analyse 
whether the quality of advice 
differed depending on the 




OTC OTC OTC OTC 
Ethical approval n/s n/s n/s [38]; 
Yes [39] 
Not explicit but implicit because 
analogous follow-up study to the 
baseline study [38, 39] 






No specific grant from any 
funding agency [39] 











University of Applied 
Sciences Neubrandenburg, 
GERMANY 
University of Applied Sciences 
Neubrandenburg, 
GERMANY 
Conflict of interest n/s n/s No No 
n/s = not specified; CS = cross-sectional; OTC = over-the-counter drugs 
 
Table 3: Scenarios 
 Scenario Key contents 
Berger 
et al. 2005 
[36] 
1 Start of consultation: The SP asks for preparation for headache. 
Type of scenario: symptom-based 
Person concerned: SP (revealed upon enquiry) 
2 Start of consultation: The SP asks for a pack of 120 tablets of Rennie. 
Type of scenario: medication-based 
Person concerned: SP (revealed upon enquiry) 
Alte 
et al. 2007 
[37] 
1 Start of consultation: The SP asks for a recommendation for headache. 
Type of scenario: symptom-based 
Person concerned: SP (revealed at the start of consultation) 
2 Start of consultation: The SP asks for a pack of Fenistil, and after receiving that the SP asks for a pack of Hoggar. 
Type of scenario: medication-based 
Person concerned: SP (revealed upon enquiry) 
Langer 
et al. 2016 
et al. 2018 
[38, 39] 
Langer 
et al. 2018 
[40] 
1 Start of consultation: The SP asks for a pack of loperamide. 
Type of scenario: medication-based 
Person concerned: SP’s 74-year-old grandmother (revealed upon enquiry) 
2 Start of consultation: The SP asks for a preparation to treat acute diarrhoea. 
Type of scenario: symptom-based 
Person concerned: SP’s 74-year-old grandmother (revealed upon enquiry) 
3 Start of consultation: The SP asks for a pack of loperamide. 
Type of scenario: medication-based 
Person concerned: SP’s 30-year-old partner (revealed upon enquiry) 
4 Start of consultation: The SP asks for a preparation to treat acute diarrhoea. 
Type of scenario: symptom-based 
Person concerned: SP’s 30-year-old partner (revealed upon enquiry) 
 
Community pharmacies 
In 1 paper [36], participation was initially offered to all 872 CPs in 
the city of Berlin, with no information provided about how the CPs 
were found. As part of a convenient sampling, in the end, 49 CPs 
were willing to participate, all of which could be visited. For the 
study region, this corresponded to a participation rate of about 6%. 
In the other paper [37], 150 CPs were selected from all 398 CPs in 
the state of Mecklenburg-Pomerania using random sampling from a 
list from the state’s Regional Chamber of Pharmacists. Due to an 
erroneous listing, 1 CP was deleted, leaving 149 CPs included. In the 
end, 146 CPs were visited, with about 37% of the CPs participating. 
All CPs received a notification letter with no CP declining to 
participate. In the other 3 papers [38-40], all 21 CPs in the northern 
German city of Neubrandenburg in the state of Mecklenburg-
Pomerania were selected using total sampling, whereby 2 papers 
[38, 39] did not provide any details about how the CPs were found 
while the other paper [40] cited in a footnote the link to an online 
pharmacy finder used to form the basic population. Because each CP 
could be visited, for these 3 papers [38-40] the participation rate 
was 100%. The CPs were not informed beforehand and thus did not 
have an opportunity to decline participation (no opt-out). The 2 
papers with advance notification [36, 37] did not report about the 
time between the advance information and the visits to the CPs. 
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Table 4: Use of the simulated patient methodology based on the 5 minor criteria: scenarios, community pharmacies, simulated patients, 
visits, data collection and performance feedback 
 Berger et al. 2005 
[36] 
Alte et al. 2007 
[37] 
Langer et al. 2016  
et al. 2018 [38, 39] 
Langer et al. 2018 
[40] 
Scenarios 
Number of scenarios 2 2 4 4 
Pre-tests of scenarios n/s n/s Yes Yes 
Community pharmacies (CPs) 
Region of CPs Berlin (city) Mecklenburg-
pomerania (state) 
Neubrandenburg (city) Neubrandenburg 
(city) 
Number of planned CPs 49 149 21 21 
Number of CPs that could not be visited 0 3 0 0 
Number of planned CPs that have been 
replaced 
n/a 0 n/a n/a 
Sample size of CPs 49 out of 872 146 out of 398 21 out of 21 21 out of 21 
Sampling type of CPs Convenient Random Total Total 
Kind of finding of CPs n/s List of Regional 
Chamber 
n/s Online pharmacy 
finder 
Advance information of CPs Yes Yes No No 
Opt-out for CPs Yes Yes No No 
Time between advance information and 
visits to CPs 
n/s n/s n/a n/a 
Simulated patients (SPs) 
Number of SPs 2 6 5 5 
Age of SPs n/s About 25 y n/s n/s 
Gender of SPs n/s 5 women, 1 man 5 women 3 women, 2 men 








Training of SPs (SPM) ‘Trained’ Yes Yes Yes 
Training of SPs (nonverbal skills) Yes n/s n/s 
Visits 
Number of planned/done visits  49/50 298/292 84/84 84/84 
Number of incomplete visits 0 6 0 0 
Number of planned visits 
that have been replaced 
n/a 0 n/a n/a 
Visit completion rate 102% 98% 100% 100% 
Each of the SPs visited 
the same CP max. 1 time 
Yes Yes Yes Yes 
Several different SPs visited the same CP No Yes Yes Yes 
Data collection and performance feedback 
Type of data collection Written Written Written Written 
Time of data collection Right after visits Right after visits Right after visits Right after visits 
Audio for data collection n/s n/s No No 
Second observer for data collection n/s n/s n/s No 
Individual performance feedback 
immediately after the visit 
Yes No n/s n/s 
Individual performance feedback  
after the last visit 
Yes Yes Yes Yes 
General performance feedback 
after the last visit 
Yes n/s Yes Yes 
n/s = not specified; n/a = not applicable 
 
Simulated patients 
In 1 paper [36] 2 persons described as ‘trained’, 1 of which was a 
pharmacy technician, carried out the role of the SPs. In the other 
paper [37] 6 pharmacy students (5 women and 1 man) in their final 
year of study and who were aged about 25 y were used as the SPs. 
The SPs were briefed and trained to carry out the visits, to complete 
the assessment forms and in interpersonal skills with licensed 
pharmacists acting as mock pharmacists. In 2 other papers [38, 39], 
5 female Master’s students were used as the SPs, who were 
described in 1 paper [38] as ‘untrained’, whereas this term was no 
longer used in the other paper [39]. In these 2 papers [38, 39], the 
use of the SPs was based on their participation in a student research 
project in their first year of graduate studies in Health Sciences. The 
follow-up study [40] used the same selection, whereby 5 students in 
Health Sciences (3 women and 2 men) were also used as SPs. In 3 
papers [38-40], the SPs received practical training by performing 
pre-tests, although these tests were not described as such. 
Visits 
In 1 paper [36], starting from 49 planned visits, ultimately 50 visits 
were successfully performed because 1 CP was visited a second time 
by a different SP due to the unblinding of the SP. The visit 
completion rate was accordingly, more than 100%. In the other 
paper [37] 292 visits were carried out, whereby the number of 
planned visits of 298 was greater due to CPs that were closed or 
could not be located. Thus, about 98% of the planned visits were 
successfully carried out. In the other 3 papers [38-40], 84 visits were 
planned in each and later successfully carried out, which 
corresponded to a visit completion rate of 100%. In the end, each of 
the SPs in all 5 papers visited the same CP a maximum of 1 time. In 4 
papers [37-40], however, the same CP was visited by several 
(different) SPs, while this only applied to 1 of the 49 visited CPs in 
the other paper [36]. 
Data collection and performance feedback 
Immediately after completing the visit, the data collection in all 5 
papers was documented in writing by the SP outside the CPs on an 
assessment form. 3 papers [38-40] omitted audio recordings and the 
other 2 papers [36, 37] did not provide any information about this. 1 
paper [40] did not use any second observers, while the other 4 papers 
[36-39] did not provide any information in this regard. In 1 paper [36] 
the SP entered the CP again immediately after the visit and provided 
the counsellor with personal, individual performance feedback. 
Another paper [37] reported that personal, individual performance 
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feedback immediately after the visit was omitted because the student 
SPs would probably not have been accepted by the pharmacy staff. In 
all 5 papers, the CPs received written individual performance feedback 
after the last visit in the study. In 4 papers [36, 38-40], the CPs also 
received written general performance feedback for all the 
participating CPs, whereby 3 papers [38-40] also reported on 
benchmarking for the CPs with anonymised competitors. 
Assessment of the quality of counselling 
The 5 included papers each used assessment forms. For this 
purpose, 3 papers [38-40] based the forms on the tools provided by 
the Federal Chamber of Pharmacies. The other 2 papers [36, 37] did 
not provide any information about this. The assessment form used 
included for scenario 19 and 14 criteria [36], 16 and 6 criteria [37] 
and 9 [38-40] criteria, respectively. The overall score measured 
across scenarios for the quality assessment was a mean of 13.8 (SD 
9.6) out of 40 points (35%) [37], a mean of 3.3 out of 9 points (37%) 
[39], a mean of 2.7 out of 9 points (30%) [40] and 277 out of 756 
points (37%) [38] In the other paper [36], rather than an overall 
assessment, a question was asked about the general impression of 
the professional knowledge and skills using German school grades 
(1 = very good to 6 = insufficient) and assessed as 2.95 (SD 1.41). 
Paper quality 
The assessment using the AXIS tool indicated that in some cases, the 
quality of the papers included differed considerably regarding the 
individual criteria (table 5). Thus, only 9 out of 20 criteria had a 
consistently positive assessment. For 11 criteria, at least 1 paper 
was negatively evaluated. 1 criterion (criterion 12: ‘Were the basic 
data adequately described?’) received a negative assessment for 4 
out of 5 papers (table 5). For 4 criteria, there were a total of 8 
deviations in the evaluation, which could be solved by a consensus of 
the two reviewers. A "substantial" [41] interrater reliability of 
κ=0.749 (p<0.001) could be measured. 
 
Table 5: Assessment using the criteria in the AXIS tool [26] 
 Berger 
et al. 2005 
[36] 
Alte 
et al. 2007 
[37] 
Langer et al. 
2016 et al. 
2017 [38, 39] 
Langer 
et al. 2018 
[40] 
Introduction 




2 Was the study design appropriate for the stated aim(s)? Yes Yes Yes Yes 
3 Was the sample size justified? No Yes Yes Yes 
4 Was the target/reference population clearly defined? (Is it clear who the 
research was about?) 
Yes Yes Yes Yes 
5 Was the sample frame taken from an appropriate population base so that it 
closely represented the target/reference population under investigation? 
Yes Yes Yes Yes 
6 Was the selection process likely to select subjects/participants that were 
representative of the target/reference population under investigation? 
No No1 Yes Yes 
7 Were measures undertaken to address and categorise non-responders? No Yes1 Yes1 Yes1 
8 Were the risk factor and outcome variables measured appropriate to the 
aims of the study? 
Yes Yes Yes Yes 
9 Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialed, piloted or published 
previously? 
No No Yes Yes 
10 Is it clear what was used to determining statistical significance and/or 
precision estimates? (e. g. p-values, confidence intervals) 
No Yes Yes Yes 
11 Were the methods (including statistical methods) sufficiently described to 
enable them to be repeated? 
No Yes Yes Yes 
Results 
12 Were the basic data adequately described? No1 Yes No1 No1 
13 Does the response rate raise concerns about non-response bias? Yes No No No 
14 If appropriate, was information about non-responders described? No Yes1 Don’t know Don’t know 
15 Were the results internally consistent? Yes Yes Yes Yes 
16 Were the results presented for all the analyses described in the methods? Yes Yes Yes Yes 
Discussion 
17 Were the authors' discussions and conclusions justified by the results? Yes Yes Yes Yes 
18 Were the limitations of the study discussed? No Yes Yes Yes 
Other 
19 Were there any funding sources or conflicts of interest that may affect the 
authors’ interpretation of the results? 
Yes Yes No No 
20 Was ethical approval or consent of participants attained? Yes Yes Don’t know 
[38]; Yes [39] 
Yes 
No1: different evaluations of the two reviewers, solved by consensus, Yes1: different evaluations of the two reviewers, solved by consensus 
 
DISCUSSION 
Applying the simulated patient methodology 
Scenarios 
The basis of each SP study is the use of at least 1 previously defined 
scenario with specific responses to be made by the SPs for the 
corresponding enquiries by the pharmacy staff. The 5 included 
papers used between 2 and 4 scenarios. Using scenarios for different 
indications–as was the case in 2 included papers [36, 37]–better 
represents routine counselling than scenarios for only 1 indication. 
The same also applies for a relevant mix of symptom-based and 
medication-based scenarios [42], as used in all the 5 papers 
included. The quality of counselling also depends greatly on the use 
of symptom-based or medication-based scenarios because as a rule, 
the quality is better for symptom-based scenarios, both in 2 included 
papers [38, 39] and in the international literature [43, 44]. On the 
other hand, the question of whether the quality of counselling differs 
between a scenario with an enquiry made for the SP themselves and 
a scenario with an enquiry on behalf of a third person indicates a 
need for future research. This issue should be investigated because 
to date this was only discussed in 1 included paper [38] and in few 
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international papers [45, 46] as a possible influencing factor for the 
quality of counselling. 
Regarding the start of the consultation to be defined for a scenario, if 
the SP discloses less information this means that the quality 
assessment is more comprehensive and thus more meaningful 
because the pharmacy staff had to extract more information by 
making enquiries. Thus, the person concerned was only revealed in 
1 scenario in an included paper [37] at the start of the consultation 
in addition to the stated symptoms. Otherwise, only a request for the 
medication was made or the symptoms were described in the other 
4 papers included [36, 38-40]. However, before the scenarios 
defined for an SP study are used, they should be tested for their 
practical functionality to be able to identify any possible weak points 
in their design and to then eliminate them. It must be recommended 
here that corresponding pre-tests be conducted outside the planned 
study region so that, particularly for a covert study design, the 
covert nature of the study is not jeopardised. Carrying out such pre-
tests was reported by 3 included papers [38-40] analogous to 
international papers [47, 48]. 
Community pharmacies 
Which CPs participated in an SP study depended on the possibility of 
locating the CPs. The basis for this was ideally a list maintained by the 
particular regional chamber of pharmacists that is made freely available 
to the public. However, such lists are not publicly available for all 
German states. But they can now be generated across Germany using 
databases available online. Because only 2 included papers [37, 40] 
reported using a list, more comprehensive reporting would be desirable 
for future SP studies. To test how up to date the CPs identified using such 
a search are, an online search (e. g. using Google) and a final covert call to 
the CPs is recommended, although not a single included paper reported 
about this. Such a procedure enables identification of whether the CPs 
are currently in operation and when they are open. This thus reduces the 
risk that CPs–as in 1 included paper [37] and in international papers [49-
51] are closed or cannot be located. 
Whether the CPs should be informed in advance is viewed 
differently internationally. For example, it is cited in favour of 
informing the CPs in advance that the quality of counselling 
increases if they are aware of the pending visits and a higher quality 
of counselling then becomes routine [42]. In addition, it is only by 
means of advance information with an additional opt-out–as was the 
case in 2 included papers [36, 37]–that informed consent can be 
obtained [14]. However, the opt-out generally leads to a selection 
bias that becomes greater the more CPs refuse to participate [52]. 
Advance information is also associated with a Hawthorne effect [13] 
and thus a distorted assessment of the quality of counselling [52]. 
This effect, which suggests that the quality of counselling of the CPs 
being visited increases because of the advance information, possibly 
resulting in a counselling situation that does not reflect real life, is 
generally larger the shorter the time between the advance 
information and the visits. Both 3 included papers [38-40] and 1 
international paper [53] attempted to resolve this dilemma by 
carrying out the visits–as suggested internationally [54]–without 
informing the CPs beforehand but informing the CPs after the visits 
that they had been carried out. Other international papers planned a 
longer interval of several months to up to 1 y between the advance 
information and the visits [47, 48, 55]. These 2 variations appear to 
be a good compromise between the need to inform the CPs on the 
one hand and the requirements for the least possible distortion to 
the quality assessment on the other. 
Simulated patients 
In order to visit the selected CPs using a scenario, at least one SP is 
required. It must be ensured that not too few (generalisability) and 
not too many SPs (standard disability) are used [16], with between 2 
and 6 SPs used in the 5 included papers and considerably more SPs 
used in the international papers [14]. The age–which was only 
reported by 1 included paper [37]–and gender of the SPs depends on 
the scenario. For example, when describing their symptoms during 
menopause the SPs should be female and of an age typical for such 
an indication. A ‘typical’ selection of SPs corresponding to the 
scenario ensures a counselling situation that reflects real life as far 
as possible. In contrast, an atypical selection of SPs for a scenario (e. 
g. an enquiry for the morning after pill for the partner by male SPs) 
enables an investigation of the quality of counselling for specific 
counselling situations [56]. 
It must also be recommended that particularly those SPs who are 
unfamiliar with the SPM complete training before starting the visits 
to familiarise themselves with the theoretical and practical 
requirements of the SPM. Carrying out pre-tests serves as practical 
training of the SPs as well as verifying the functionality of the 
collection form and the scenarios. Whether training of non-verbal 
skills is also necessary should be decided based on each scenario. 
This could be useful to non-verbalize as authentically as possible 
when, for example, the SP indicates that they are in pain. Only 1 
included paper [37] provided concrete information about the 
different forms of training of the SPs. The extent and content of such 
training can vary considerably [14] and can range, for example, from 
paper manual training, interactive web-based training to mock 
mystery shopping training with feedback. 
Further research is needed on whether experts or non-experts should 
be used as SPs. In a recent SP systematic review, it was shown–
analogous to 4 of the included papers [37-40]–that internationally, 
non-experts are predominantly used as SPs [14]. According to Haller 
the use of professional SPs or specialist pharmaceutical personnel–as 
reported by 1 included paper [36] or in the internal pharmacy SP 
studies by the German chambers of pharmacists [33-35]–is 
discouraged because these persons may have different benchmarks 
than the average customer would [57]. Ultimately, the SPs should have 
reasonable intelligence and emotional maturity as well as being 
trustworthy [16] to not have to exclude the data due to concerns about 
their correctness, which was not the case in any of the included papers 
but was so in 1 international paper [58]. 
Visits 
A consultation lacking in authenticity–possibly also reinforced by 
informing the CPs too recently in advance–could be the reason why 
visits are detected by the pharmacy staff, as was the case in 1 
included paper [36] and 1 international paper [58]. The risk of 
detection would then also be greater if the same SP repeatedly visits 
the same CP either with several scenarios or the same scenario in an 
attempt to increase the validity of the quality assessment. Therefore, 
it must be recommended that a CP is only visited once at most by the 
same SP, as was the case in all 5 included papers and in the 
international literature [42, 58]. It must also be ensured, particularly 
for several visits using the same scenario, that the (different) SPs 
carry out the visits with a certain interval between to avoid 
detection. 
If visits that are detected by the pharmacy staff are excluded from 
the data analysis and are also not repeated or replaced, this leads to 
a difference between the planned and successfully carried out visits 
as do other causes such as concerns about the correctness of the 
data that is usually documented by the SPs [58] or CPs that are 
closed or cannot be located [59]. This difference is defined as the 
visit completion rate and was below 100% in only 1 included paper 
with a value of 98% [37]; in some international papers, the rate was 
as low as 91% [58] and 82% [59]. Because the visit completion rate 
can also affect the quality assessment of the study, it should, 
therefore, always be reported analogously to the response rate in 
self-reported questionnaires [14]. While this was implemented by all 
the included papers, this information was missing in some 
international papers [14]. 
Data collection and performance feedback 
The data for the completed visits must then be appropriately 
collected. In this regard, it must be recommended that the SPs 
themselves document the data immediately after completing the 
visits, as was the case in all 5 included papers, to reduce distortions 
in the quality assessment due to potentially missing or erroneously 
recalled information [15]. Instead of documenting the data in 
writing in the first place, as was the case in all 5 included papers, the 
data could immediately be entered digitally for the analysis to save 
resources and avoid error-prone transfer from the written 
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documentation and the subsequent digitalisation. For quality 
assurance, the data could be supplemented with audio recordings 
[60] or by a second observer accompanying the SP [61] and thus 
recall bias could be avoided or at least reduced, although this was 
either not considered or not reported in the 5 included papers. 
Because audio recordings, at least in Germany, always require the 
consent of the person being recorded and therefore the person must 
always be informed [62], they do not suit a covert study design, at 
least with a short notification interval, and usually create a selection 
bias due to a possible opt-out. The use of 1 or more second 
observers requires additional human resources. It must also be 
ensured that this person, who may be distracting for the pharmacy 
staff, does not lead to the detection of the visit. 
With a view to the effectiveness, we recommend providing any 
individual performance feedback immediately after the visit because 
the pharmacy staff’s memory of the counselling they provided is best 
then [15]. However, this procedure, which was carried out by 1 
included paper [36], is not useful with repeated visits to the same CP 
and the aim of making the most objective assessment possible of the 
quality of counselling. The reason is that short-term sensitisation of 
the pharmacy staff cannot be ruled out as a result of providing 
repeated immediate individual performance feedback, which in turn 
could lead to distortions in the quality assessment for subsequent 
visits. Therefore, in such cases, the individual performance feedback 
should only be provided after the final visit in an SP study. This 
procedure, which was implemented by all 5 included papers, would 
not be necessary if the objective was to sensitise the pharmacy staff to 
a high quality of counselling by making repeated visits to the same CPs 
[42] with subsequent feedback loops–taking into account any possible 
familiarisation effect [63]. The individual performance feedback after 
the final visit is even more effective if it is supplemented by general 
performance feedback, as was the case in 4 included papers [36, 38-
40]. Ideally, this should then be supplemented by benchmarking, as 
was the case in 3 included papers [38-40] whereby the CPs were 
informed about their competitors’ position.  
In order to ensure the effectiveness of personal individual 
performance feedback, it should be given by a person accepted by the 
pharmacy staff (e. g. a pharmacist) due to the possible problem of 
acceptance of, for example, students [37]. Whether individual 
performance feedback leads to an improvement in the quality of 
counselling should be reviewed in a follow-up study, as had already 
been carried out in 1 included paper [40] as well as in international 
papers [42, 64, 65]. However, feedback as a form of intervention 
proved to be ineffective, not only in 1 included paper [40] but also for 
certain indications (e. g. acute diarrhoea) in an international follow-up 
study [42]. Because SP studies conducted internally by pharmacies in 
Germany also use feedback as an instrument for quality improvement 
[33-35], these study results raise the question of whether such 
measures are effective. Presumably, considerably more powerful 
interventions (e. g. training) are required to improve the quality of 
counselling [64, 65]. Regarding successful interventions, future SP 
studies should pose the question of how sustainable the 
improvements achieved in this way are, that is, how does the quality of 
counselling change once the intervention measures are discontinued. 
Assessment of the quality of counselling 
For the assessment of the quality of counselling, an appropriate 
assessment form is required. However, a suitable assessment form 
must first be developed using the tools provided by the Federal 
Chamber of Pharmacies, as was done in 3 included papers [38-40]. 
As a supplement to the tools, standardised assessment forms, which 
have not been available in Germany to date, could be developed 
which would enable better comparisons of the quality assessment. 
Regarding the design of the assessment form, the number of criteria 
should not be greater than necessary, with 1 included paper [36] 
using up to 19 criteria. Because of the large number of criteria, there 
is a risk of recall bias for the data being documented if the data 
collection is based solely on the memory protocol of the SP and is 
not supported by additional audio recordings or the use of a second 
observer. 
The quality of counselling was assessed in all 5 included papers as 
being rather poor. These results are congruent with those from the 
covert SP studies conducted by Stiftung Warentest (excluded from 
this systematic review because of inadequately transparent 
information about the methodology) [29-32], an independent 
German consumer organisation. In stark contrast to this, 
predominantly good to very good results were reported in SP 
studies that were conducted by the regional chambers of 
pharmacists (also excluded from this systematic review because of 
inadequately transparent information about the methodology) [33-
35]. This leads to the general question of whether the SP studies 
organised by the various chambers, as maintained by the 
professional associations, actually ensure the greatest possible 
degree of objectivity and neutrality [33-35] or whether there is 
rather a conflict of interest if there are institutional links between 
the object of the study and the client that commissioned the study. 
Positive results were also reported in an older questionnaire-based 
study, but this study is prone to a social desirability bias and a 
Hawthorne effect [66]. 
The rather poor assessment of the quality of counselling in the 
included papers should make both the Federal Union of German 
Associations of Pharmacists (ABDA) and legislators aware that they 
must greatly intensify their previous quality management efforts. In 
this context, as part of the pharmacy degree (pharmacist) or 
professional training (pharmaceutical technical assistant), patient 
consultations should therefore be more intensively trained. 
Mandatory continuing education would also be a possible option for 
improvement. Another option would be to expand the use of 
checklists [67], which in Germany are only currently used for 
counselling on the morning after pill. Finally, regular, independent 
reviews with an appropriate sanction mechanism could also be 
considered to provide the necessary stimulus to sustainably increase 
the quality of counselling [45]. 
Strengths and limitations of the review 
As far as the authors are aware this is the first review that has 
systematically investigated the use of the SPM for assessing the quality 
of counselling in German CPs. Another strength is that the literature 
search was conducted using a high number of English terms. Because 
many synonyms for the term ‘simulated patient’ are used in the 
literature, however, it is possible that potential search terms were not 
considered. In addition, the aim of presenting the current status of the 
object of investigation is not compatible with the possibility of also 
finding papers that were published before 2005. Forward snowballing 
was not carried out, which also may have led to additional relevant 
papers being identified [24]. For the reasons indicated, it is possible 
that there is a publication bias in the search results. The search results 
may also have a language bias because we only searched for papers 
that were published in German or English. 
Distortions in the study results for this systematic review also 
cannot be ruled out. Thus, for the procedure for the data extraction, 
only the reporting of the papers was significant. In addition, only 2 
reviewers were involved in the study. Furthermore, only 23 records 
could be identified and only 5 papers could be included. On the other 
hand, few identified records [68, 69] and very few [70-74] or no [75, 
76] included studies are not unusual in systematic reviews. Also, the 
included papers have a relatively low level of evidence (CS design) 
and moreover 1 paper [36] used only a small convenient sample of a 
major city and 3 papers [38-40] are only representatives of a 
medium-sized city. For these reasons, the present study results 
should be interpreted with caution. 
CONCLUSION 
Only an extremely small number of papers, unlike other countries, 
could be included for Germany and all of them were conducted in 
north-eastern Germany. More SP studies that are conducted in other 
regions in Germany are therefore urgently required. The included 
papers demonstrate that the quality of counselling in the CPs that 
were investigated with an SPM approach showed a considerable 
need for improvement. In addition, the deficits identified here for 
the use of the SPM should be avoided in future papers. It is also 
recommended that the SPM be reported in future papers using 
uniform reporting standards that must be developed to ensure 
greater ease of comparison. 
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